Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 150, Issue 1, 1994, Pages 113-122

  Steinberg, Kenneth P ^a   Milberg, John A ^b   Martin, Thomas R ^b   Maunder, Richard J ^b   Cockrill, Barbara A ^b   Hudson, Leonard D ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CELL POPULATION; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG ALVEOLITIS; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEPSIS;

EID: 0028243988     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.150.1.8025736     Document Type: Article

References (38)

1. Idell S, Cohen AB. Bronchoalveolar lavage in patients with the adult respiratory distress syndrome. Clin Chest Med 1985;6:459-71.
2. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982;3:35-56.
3. Holter JF, Weiland JE, Pacht ER, Gadek JE, Davis WB. Protein perme-ability in the adult respiratory distress syndrome. Loss of size selectivity of the alveolar epithelium. J Clin Invest 1986;78:1513-22.
4. Fowler AA, Hyers TM, Fisher BJ, Bechard DE, Center RM, Webster RO. The adult respiratory distress syndrome: cell populations and soluble mediators in the air spaces of patients at high risk. Am Rev Respir Dis 1987;136:1225-31.
5. McGuire WW, Spragg RG, Cohen AM, Cochrane CG. Studies on the pathogenesis of the adult respiratory distress syndrome. J Clin Invest 1982; 69:543-53.
6. Weiland JE, Davis WB, Holter JF, Mohammed JR, Dorinsky PM, Gadek JE. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathophysiologic significance. Am Rev Respir Dis 1986; 133:218-25.
7. Martin TR, Pistorese BP, Hudson LD, Maunder RJ. The function of lung and blood neutrophils in patients with the adult respiratory distress syndrome: implications for the pathogenesis of lung infections. Am Rev Respir Dis 1991;144:254-62.
8. Repine JE, Beehler CJ. Neutrophils and adult respiratory distress syndrome: two interlocking perspectives in 1991. Am Rev Respir Dis 1991;144:251-2.
9. Lee CT, Fein AM, Lippman M, Holtzman H, Kimbel P, Weinbaum G. Elastolytic activity in pulmonary lavage fluid from patients with the adult respiratory distress syndrome. N Engl J Med 1981;304:192-6.
10. Baldwin SR, Simon RH, Gram CM, Ketai CH, Boxer LA, Devall LJ. Oxidant activity in expired breath from patients with adult respiratory distress syndrome. Lancet 1986;1:11-14.
11. Cochrane CG, Spragg R, Revak SD. Pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 1983;71:754-61.
12. Stephenson AH, Lonigro AJ, Hyers TM, Webster RO, Fowler AA. Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988;138:714-9.
13. 4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J Clin Immunol 1984;4:479-83.
14. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992;146:427-32.
15. Hyers TM, Tricomi SM, Dettenmeier PA, Fowler AA. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am Rev Respir Dis 1991;144: 268-71.
16. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis 1992;145:1016-22.
17. Larsen GL, Mitchell BC, Harper TB, Henson PM. The pulmonary response of C5 sufficient and deficient mice to Pseudomonas aeruginosa. Am Rev Respir Dis 1982;126:306-11.
18. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg 1982; 144:124-9.
19. Montgomery AB, Stager MA, Carrico CJ, Hudson LD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985;132:485-9.
20. Baker SP, O'Neill B, Hadden W, Long W. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974;14:187-96.
21. Markwell MA, Hoas SMK, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-10.
22. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
23. 4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 1989;84:1609-19.
24. Cherniack RM, Banks DE, Bell DY, Davis GS, Hugh JM, King TE Jr. The BAL Cooperative Study Group. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis 1990;145(5, part 2):S169-S202.
25. Mathew J, Altman D, Campbell M, Royston P. Analysis of serial measurements in medical research. Brit Med J 1990;300:230-5.
26. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720-3.
27. Selvin S. Statistical analysis of epidemiologic data. New York: Oxford University Press, 1991;310-38.
28. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. Sepsis syndrome: a valid clinical entity. Crit Care Med 1989;17:389-93.
29. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol 1975;78:71-100.
30. Henson PM, Larsen GL, Henson JE, Newman SL, Musson RA, Leslie CC. Resolution of pulmonary inflammation. Fed Proc 1984;43:2799-806.
31. Dal Nogare AR, Toews GB. Characteristics of alveolar macrophages in an animal model of resolving pulmonary inflammation. Am Rev Respir Dis 1990;142:660-7.
32. Brieland JK, Kunkel RG, Fantone JC. Pulmonary alveolar macrophage function during acute inflammatory lung injury. Am Rev Respir Dis 1987;135:1300-6.
33. Campbell EJ. Human leukocyte elastase, cathepsin G, and lactoferrin: family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor. Proc Natl Acad Sci USA 1982;79:6941-5.
34. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982;156:430-42.
35. McDonald RJ, Berger EM, Repine JE. Alveolar macrophage antioxidants prevent hydrogen peroxide-mediated lung damage. Am Rev Respir Dis 1991;143:1088-91.
36. Benzer A, Mitterschiffthaler, Marosi M. Prediction of non-survival after trauma: Innsbrucht Coma Scale. Lancet 1991;338:977-8.
37. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
38. Keinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. 2nd ed. Boston: PWS-Kent, 1988:345.